These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12754511)

  • 41. Evaluating the oncogenic risk of residual DNA in vaccines: the potential role of transgenic mice.
    Onions D
    Dev Biol (Basel); 2001; 106():135-42; discussion 143-60. PubMed ID: 11761227
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A role for E2F activities in determining the fate of Myc-induced lymphomagenesis.
    Rempel RE; Mori S; Gasparetto M; Glozak MA; Andrechek ER; Adler SB; Laakso NM; Lagoo AS; Storms R; Smith C; Nevins JR
    PLoS Genet; 2009 Sep; 5(9):e1000640. PubMed ID: 19749980
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selective roles of E2Fs for ErbB2- and Myc-mediated mammary tumorigenesis.
    Wu L; de Bruin A; Wang H; Simmons T; Cleghorn W; Goldenberg LE; Sites E; Sandy A; Trimboli A; Fernandez SA; Eng C; Shapiro C; Leone G
    Oncogene; 2015 Jan; 34(1):119-28. PubMed ID: 24276244
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fundamental patterns underlying gene expression profiles: simplicity from complexity.
    Holter NS; Mitra M; Maritan A; Cieplak M; Banavar JR; Fedoroff NV
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8409-14. PubMed ID: 10890920
    [TBL] [Abstract][Full Text] [Related]  

  • 45. myc genes and their deregulation in lung cancer.
    Saksela K
    J Cell Biochem; 1990 Mar; 42(3):153-80. PubMed ID: 2180966
    [No Abstract]   [Full Text] [Related]  

  • 46. Initiating oncogenic event determines gene-expression patterns of human breast cancer models.
    Desai KV; Xiao N; Wang W; Gangi L; Greene J; Powell JI; Dickson R; Furth P; Hunter K; Kucherlapati R; Simon R; Liu ET; Green JE
    Proc Natl Acad Sci U S A; 2002 May; 99(10):6967-72. PubMed ID: 12011455
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification and characterization of transcription factor target genes using gene-targeted mice.
    DeRyckere D; DeGregori J
    Methods; 2002 Jan; 26(1):57-75. PubMed ID: 12054905
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Different H2 haplotypes have a strong influence on oncogene action.
    Ember I; Kiss I; Nowrasteh G
    Anticancer Res; 1999; 19(2A):1181-5. PubMed ID: 10368672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Relation between oncogenes, aging and pathogenesis of tumor].
    Tang ZQ; Zhang ZY; Tong TJ
    Sheng Li Ke Xue Jin Zhan; 1992 Jan; 23(1):58-61. PubMed ID: 1411426
    [No Abstract]   [Full Text] [Related]  

  • 50. Model genetic circuits encoding autoregulatory transcription factors.
    Keller AD
    J Theor Biol; 1995 Jan; 172(2):169-85. PubMed ID: 7891455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. E2F2 suppresses Myc-induced proliferation and tumorigenesis.
    Pusapati RV; Weaks RL; Rounbehler RJ; McArthur MJ; Johnson DG
    Mol Carcinog; 2010 Feb; 49(2):152-6. PubMed ID: 19798698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modeling time-dependent transcription effects of HER2 oncogene and discovery of a role for E2F2 in breast cancer cell-matrix adhesion.
    Bollig-Fischer A; Marchetti L; Mitrea C; Wu J; Kruger A; Manca V; Drăghici S
    Bioinformatics; 2014 Nov; 30(21):3036-43. PubMed ID: 25028721
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gene discovery using the serial analysis of gene expression technique: implications for cancer research.
    Polyak K; Riggins GJ
    J Clin Oncol; 2001 Jun; 19(11):2948-58. PubMed ID: 11387368
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gene network modeling via TopNet reveals functional dependencies between diverse tumor-critical mediator genes.
    McMurray HR; Ambeskovic A; Newman LA; Aldersley J; Balakrishnan V; Smith B; Stern HA; Land H; McCall MN
    Cell Rep; 2021 Dec; 37(12):110136. PubMed ID: 34936873
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Flipping the oncogene switch: illumination of tumor maintenance and regression.
    Chin L; DePinho RA
    Trends Genet; 2000 Apr; 16(4):147-50. PubMed ID: 10729826
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dynamic modeling of gene expression data.
    Holter NS; Maritan A; Cieplak M; Fedoroff NV; Banavar JR
    Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1693-8. PubMed ID: 11172013
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oncogenic conversion by regulatory changes in transcription factors.
    Lewin B
    Cell; 1991 Jan; 64(2):303-12. PubMed ID: 1988149
    [No Abstract]   [Full Text] [Related]  

  • 58. Pathway Activation Analysis for Pan-Cancer Personalized Characterization Based on Riemannian Manifold.
    Li X; Hao J; Li J; Zhao Z; Shang X; Li M
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673997
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HOOK1 Inhibits the Progression of Renal Cell Carcinoma via TGF-β and TNFSF13B/VEGF-A Axis.
    Yin L; Li W; Chen X; Wang R; Zhang T; Meng J; Li Z; Xu L; Yin R; Cheng B; Yang H
    Adv Sci (Weinh); 2023 Jun; 10(17):e2206955. PubMed ID: 37085921
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methylglyoxal: a novel upstream regulator of DNA methylation.
    Dube G; Tiamiou A; Bizet M; Boumahd Y; Gasmi I; Crake R; Bellier J; Nokin MJ; Calonne E; Deplus R; Wissocq T; Peulen O; Castronovo V; Fuks F; Bellahcène A
    J Exp Clin Cancer Res; 2023 Mar; 42(1):78. PubMed ID: 36998085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.